nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—ABCB1—Sorafenib—thyroid cancer	0.0489	0.281	CbGbCtD
Estramustine—CYP3A4—Vandetanib—thyroid cancer	0.0486	0.279	CbGbCtD
Estramustine—ABCB1—Doxorubicin—thyroid cancer	0.0297	0.17	CbGbCtD
Estramustine—CYP3A4—Sorafenib—thyroid cancer	0.0293	0.168	CbGbCtD
Estramustine—MAP1A—saliva-secreting gland—thyroid cancer	0.029	0.127	CbGeAlD
Estramustine—MAP1A—trachea—thyroid cancer	0.0223	0.0979	CbGeAlD
Estramustine—MAP2—neck—thyroid cancer	0.0211	0.0924	CbGeAlD
Estramustine—Thromboembolism—Sorafenib—thyroid cancer	0.0202	0.0515	CcSEcCtD
Estramustine—CYP3A4—Doxorubicin—thyroid cancer	0.0178	0.102	CbGbCtD
Estramustine—MAP1A—thyroid gland—thyroid cancer	0.0177	0.0774	CbGeAlD
Estramustine—MAP2—saliva-secreting gland—thyroid cancer	0.0165	0.0721	CbGeAlD
Estramustine—MAP1A—head—thyroid cancer	0.0157	0.0687	CbGeAlD
Estramustine—Hoarseness—Sorafenib—thyroid cancer	0.0146	0.0373	CcSEcCtD
Estramustine—Hypercalcaemia—Vandetanib—thyroid cancer	0.0137	0.035	CcSEcCtD
Estramustine—ESR2—neck—thyroid cancer	0.0137	0.0599	CbGeAlD
Estramustine—Embolism venous—Sorafenib—thyroid cancer	0.0127	0.0325	CcSEcCtD
Estramustine—MAP2—trachea—thyroid cancer	0.0127	0.0556	CbGeAlD
Estramustine—MAP1A—lymph node—thyroid cancer	0.011	0.0481	CbGeAlD
Estramustine—ESR2—Nuclear Receptors—THRB—thyroid cancer	0.0102	0.0495	CbGpPWpGaD
Estramustine—MAP2—thyroid gland—thyroid cancer	0.01	0.044	CbGeAlD
Estramustine—Embolism—Sorafenib—thyroid cancer	0.00999	0.0255	CcSEcCtD
Estramustine—ESR1—neck—thyroid cancer	0.00936	0.041	CbGeAlD
Estramustine—MAP2—SIDS Susceptibility Pathways—RET—thyroid cancer	0.0092	0.0446	CbGpPWpGaD
Estramustine—MAP2—head—thyroid cancer	0.00891	0.039	CbGeAlD
Estramustine—MAP2—MAPK Cascade—BRAF—thyroid cancer	0.00858	0.0416	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00855	0.0415	CbGpPWpGaD
Estramustine—ESR2—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00806	0.0391	CbGpPWpGaD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—KRT19—thyroid cancer	0.00802	0.0389	CbGpPWpGaD
Estramustine—Dysphonia—Sorafenib—thyroid cancer	0.00779	0.0199	CcSEcCtD
Estramustine—Thromboembolism—Epirubicin—thyroid cancer	0.00745	0.019	CcSEcCtD
Estramustine—Lethargy—Vandetanib—thyroid cancer	0.00704	0.018	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Vandetanib—thyroid cancer	0.0069	0.0176	CcSEcCtD
Estramustine—Thromboembolism—Doxorubicin—thyroid cancer	0.00689	0.0176	CcSEcCtD
Estramustine—Cardiac arrest—Vandetanib—thyroid cancer	0.00656	0.0168	CcSEcCtD
Estramustine—ESR2—thyroid gland—thyroid cancer	0.00651	0.0285	CbGeAlD
Estramustine—Dry skin—Vandetanib—thyroid cancer	0.00632	0.0162	CcSEcCtD
Estramustine—MAP2—lymph node—thyroid cancer	0.00624	0.0273	CbGeAlD
Estramustine—Skin exfoliation—Sorafenib—thyroid cancer	0.00612	0.0156	CcSEcCtD
Estramustine—ESR2—head—thyroid cancer	0.00577	0.0253	CbGeAlD
Estramustine—Gynaecomastia—Sorafenib—thyroid cancer	0.00574	0.0147	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00568	0.0275	CbGpPWpGaD
Estramustine—MAP2—MAPK Cascade—NRAS—thyroid cancer	0.00539	0.0262	CbGpPWpGaD
Estramustine—Depression—Vandetanib—thyroid cancer	0.0053	0.0136	CcSEcCtD
Estramustine—ESR1—Nuclear Receptors—THRB—thyroid cancer	0.00514	0.0249	CbGpPWpGaD
Estramustine—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00513	0.0131	CcSEcCtD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—CITED1—thyroid cancer	0.00512	0.0248	CbGpPWpGaD
Estramustine—Myelosuppression—Epirubicin—thyroid cancer	0.00505	0.0129	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.00475	0.023	CbGpPWpGaD
Estramustine—Embolism venous—Epirubicin—thyroid cancer	0.00469	0.012	CcSEcCtD
Estramustine—Myelosuppression—Doxorubicin—thyroid cancer	0.00467	0.012	CcSEcCtD
Estramustine—MAP2—MAPK Cascade—KRAS—thyroid cancer	0.00464	0.0225	CbGpPWpGaD
Estramustine—Hypernatraemia—Epirubicin—thyroid cancer	0.00451	0.0115	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—SST—thyroid cancer	0.00449	0.0218	CbGpPWpGaD
Estramustine—ESR1—thyroid gland—thyroid cancer	0.00446	0.0195	CbGeAlD
Estramustine—Mood swings—Sorafenib—thyroid cancer	0.00441	0.0113	CcSEcCtD
Estramustine—Embolism venous—Doxorubicin—thyroid cancer	0.00434	0.0111	CcSEcCtD
Estramustine—ESR2—Nuclear Receptors—RXRA—thyroid cancer	0.00433	0.021	CbGpPWpGaD
Estramustine—Dry skin—Sorafenib—thyroid cancer	0.00426	0.0109	CcSEcCtD
Estramustine—Alopecia—Vandetanib—thyroid cancer	0.00422	0.0108	CcSEcCtD
Estramustine—Hypernatraemia—Doxorubicin—thyroid cancer	0.00417	0.0107	CcSEcCtD
Estramustine—ESR1—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00407	0.0197	CbGpPWpGaD
Estramustine—ESR2—lymph node—thyroid cancer	0.00404	0.0177	CbGeAlD
Estramustine—Lacrimation—Epirubicin—thyroid cancer	0.00403	0.0103	CcSEcCtD
Estramustine—Muscle spasms—Vandetanib—thyroid cancer	0.00399	0.0102	CcSEcCtD
Estramustine—ESR1—head—thyroid cancer	0.00395	0.0173	CbGeAlD
Estramustine—MAP2—MAPK Cascade—HRAS—thyroid cancer	0.00395	0.0191	CbGpPWpGaD
Estramustine—Abdominal discomfort—Sorafenib—thyroid cancer	0.00386	0.00986	CcSEcCtD
Estramustine—Lacrimation—Doxorubicin—thyroid cancer	0.00373	0.00953	CcSEcCtD
Estramustine—Erectile dysfunction—Sorafenib—thyroid cancer	0.0037	0.00947	CcSEcCtD
Estramustine—Embolism—Epirubicin—thyroid cancer	0.00369	0.00943	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00355	0.0172	CbGpPWpGaD
Estramustine—Chest pain—Vandetanib—thyroid cancer	0.00354	0.00904	CcSEcCtD
Estramustine—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00353	0.00904	CcSEcCtD
Estramustine—Anxiety—Vandetanib—thyroid cancer	0.00352	0.00901	CcSEcCtD
Estramustine—Myocardial infarction—Sorafenib—thyroid cancer	0.00351	0.00899	CcSEcCtD
Estramustine—ESR2—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00342	0.0166	CbGpPWpGaD
Estramustine—Embolism—Doxorubicin—thyroid cancer	0.00341	0.00873	CcSEcCtD
Estramustine—Hypercalcaemia—Epirubicin—thyroid cancer	0.00341	0.00872	CcSEcCtD
Estramustine—Oedema—Vandetanib—thyroid cancer	0.00339	0.00867	CcSEcCtD
Estramustine—Thrombocytopenia—Vandetanib—thyroid cancer	0.00332	0.00849	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.0033	0.016	CbGpPWpGaD
Estramustine—Hypercalcaemia—Doxorubicin—thyroid cancer	0.00315	0.00807	CcSEcCtD
Estramustine—Insomnia—Vandetanib—thyroid cancer	0.00307	0.00784	CcSEcCtD
Estramustine—Dyspnoea—Vandetanib—thyroid cancer	0.00302	0.00773	CcSEcCtD
Estramustine—MAP2—LKB1 signaling events—TP53—thyroid cancer	0.00301	0.0146	CbGpPWpGaD
Estramustine—Tinnitus—Sorafenib—thyroid cancer	0.003	0.00767	CcSEcCtD
Estramustine—Flushing—Sorafenib—thyroid cancer	0.00299	0.00764	CcSEcCtD
Estramustine—Decreased appetite—Vandetanib—thyroid cancer	0.00295	0.00753	CcSEcCtD
Estramustine—Dysphonia—Epirubicin—thyroid cancer	0.00288	0.00736	CcSEcCtD
Estramustine—Alopecia—Sorafenib—thyroid cancer	0.00284	0.00727	CcSEcCtD
Estramustine—ESR1—lymph node—thyroid cancer	0.00277	0.0121	CbGeAlD
Estramustine—ESR2—Nuclear Receptors—PPARG—thyroid cancer	0.00274	0.0133	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.0027	0.0131	CbGpPWpGaD
Estramustine—Muscle spasms—Sorafenib—thyroid cancer	0.00269	0.00689	CcSEcCtD
Estramustine—Dysphonia—Doxorubicin—thyroid cancer	0.00266	0.00681	CcSEcCtD
Estramustine—Lacrimation increased—Epirubicin—thyroid cancer	0.00257	0.00657	CcSEcCtD
Estramustine—Leukopenia—Sorafenib—thyroid cancer	0.00251	0.00641	CcSEcCtD
Estramustine—Pruritus—Vandetanib—thyroid cancer	0.0024	0.00613	CcSEcCtD
Estramustine—Lacrimation increased—Doxorubicin—thyroid cancer	0.00238	0.00608	CcSEcCtD
Estramustine—Diarrhoea—Vandetanib—thyroid cancer	0.00232	0.00593	CcSEcCtD
Estramustine—Skin exfoliation—Epirubicin—thyroid cancer	0.00226	0.00578	CcSEcCtD
Estramustine—Thrombocytopenia—Sorafenib—thyroid cancer	0.00224	0.00572	CcSEcCtD
Estramustine—ABCB1—trachea—thyroid cancer	0.00223	0.00975	CbGeAlD
Estramustine—ESR2—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00219	0.0106	CbGpPWpGaD
Estramustine—ESR1—Nuclear Receptors—RXRA—thyroid cancer	0.00219	0.0106	CbGpPWpGaD
Estramustine—Anorexia—Sorafenib—thyroid cancer	0.00218	0.00557	CcSEcCtD
Estramustine—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00218	0.00556	CcSEcCtD
Estramustine—ESR1—FOXM1 transcription factor network—CDK1—thyroid cancer	0.00217	0.0105	CbGpPWpGaD
Estramustine—ESR2—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00216	0.0105	CbGpPWpGaD
Estramustine—Vomiting—Vandetanib—thyroid cancer	0.00216	0.00551	CcSEcCtD
Estramustine—Rash—Vandetanib—thyroid cancer	0.00214	0.00547	CcSEcCtD
Estramustine—Dermatitis—Vandetanib—thyroid cancer	0.00214	0.00546	CcSEcCtD
Estramustine—Headache—Vandetanib—thyroid cancer	0.00212	0.00543	CcSEcCtD
Estramustine—Skin exfoliation—Doxorubicin—thyroid cancer	0.00209	0.00535	CcSEcCtD
Estramustine—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.00207	0.0101	CbGpPWpGaD
Estramustine—Dyspnoea—Sorafenib—thyroid cancer	0.00204	0.00521	CcSEcCtD
Estramustine—Nausea—Vandetanib—thyroid cancer	0.00201	0.00515	CcSEcCtD
Estramustine—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.00201	0.00515	CcSEcCtD
Estramustine—ESR1—Estrogen signaling pathway—BRAF—thyroid cancer	0.00201	0.00974	CbGpPWpGaD
Estramustine—Decreased appetite—Sorafenib—thyroid cancer	0.00199	0.00508	CcSEcCtD
Estramustine—Thrombophlebitis—Epirubicin—thyroid cancer	0.00199	0.00508	CcSEcCtD
Estramustine—ESR2—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00193	0.00934	CbGpPWpGaD
Estramustine—Eye pain—Epirubicin—thyroid cancer	0.0019	0.00487	CcSEcCtD
Estramustine—Cardiac failure congestive—Epirubicin—thyroid cancer	0.0019	0.00485	CcSEcCtD
Estramustine—ESR1—Nuclear signaling by ERBB4—NRG1—thyroid cancer	0.00185	0.00898	CbGpPWpGaD
Estramustine—Hot flush—Epirubicin—thyroid cancer	0.00184	0.0047	CcSEcCtD
Estramustine—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00184	0.0047	CcSEcCtD
Estramustine—Menopausal symptoms—Epirubicin—thyroid cancer	0.00182	0.00466	CcSEcCtD
Estramustine—Eye pain—Doxorubicin—thyroid cancer	0.00176	0.00451	CcSEcCtD
Estramustine—ABCB1—thyroid gland—thyroid cancer	0.00176	0.00771	CbGeAlD
Estramustine—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00175	0.00449	CcSEcCtD
Estramustine—Lethargy—Epirubicin—thyroid cancer	0.00175	0.00449	CcSEcCtD
Estramustine—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00175	0.00449	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—SST—thyroid cancer	0.00173	0.0084	CbGpPWpGaD
Estramustine—ESR1—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00173	0.00838	CbGpPWpGaD
Estramustine—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00172	0.0044	CcSEcCtD
Estramustine—Hot flush—Doxorubicin—thyroid cancer	0.0017	0.00435	CcSEcCtD
Estramustine—Affect lability—Epirubicin—thyroid cancer	0.00169	0.00433	CcSEcCtD
Estramustine—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00169	0.00431	CcSEcCtD
Estramustine—Cardiac arrest—Epirubicin—thyroid cancer	0.00164	0.00418	CcSEcCtD
Estramustine—Mood swings—Epirubicin—thyroid cancer	0.00163	0.00416	CcSEcCtD
Estramustine—Lethargy—Doxorubicin—thyroid cancer	0.00162	0.00415	CcSEcCtD
Estramustine—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00162	0.00415	CcSEcCtD
Estramustine—Pruritus—Sorafenib—thyroid cancer	0.00162	0.00414	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.00159	0.00407	CcSEcCtD
Estramustine—Liver function test abnormal—Epirubicin—thyroid cancer	0.00159	0.00406	CcSEcCtD
Estramustine—Dry skin—Epirubicin—thyroid cancer	0.00158	0.00403	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—NRAS—thyroid cancer	0.00158	0.00764	CbGpPWpGaD
Estramustine—Affect lability—Doxorubicin—thyroid cancer	0.00157	0.004	CcSEcCtD
Estramustine—Diarrhoea—Sorafenib—thyroid cancer	0.00156	0.004	CcSEcCtD
Estramustine—ABCB1—head—thyroid cancer	0.00156	0.00684	CbGeAlD
Estramustine—Cardiac arrest—Doxorubicin—thyroid cancer	0.00151	0.00387	CcSEcCtD
Estramustine—Mood swings—Doxorubicin—thyroid cancer	0.00151	0.00385	CcSEcCtD
Estramustine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00147	0.00376	CcSEcCtD
Estramustine—Dry skin—Doxorubicin—thyroid cancer	0.00146	0.00373	CcSEcCtD
Estramustine—Vomiting—Sorafenib—thyroid cancer	0.00145	0.00372	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—CDK1—thyroid cancer	0.00144	0.007	CbGpPWpGaD
Estramustine—Rash—Sorafenib—thyroid cancer	0.00144	0.00369	CcSEcCtD
Estramustine—Dermatitis—Sorafenib—thyroid cancer	0.00144	0.00368	CcSEcCtD
Estramustine—Headache—Sorafenib—thyroid cancer	0.00143	0.00366	CcSEcCtD
Estramustine—Pancytopenia—Epirubicin—thyroid cancer	0.00141	0.00361	CcSEcCtD
Estramustine—ESR2—Generic Transcription Pathway—THRB—thyroid cancer	0.00139	0.00675	CbGpPWpGaD
Estramustine—ESR1—Nuclear Receptors—PPARG—thyroid cancer	0.00138	0.00669	CbGpPWpGaD
Estramustine—Nausea—Sorafenib—thyroid cancer	0.00136	0.00347	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—KRAS—thyroid cancer	0.00136	0.00658	CbGpPWpGaD
Estramustine—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00133	0.00643	CbGpPWpGaD
Estramustine—Pancytopenia—Doxorubicin—thyroid cancer	0.00131	0.00334	CcSEcCtD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.00128	0.00622	CbGpPWpGaD
Estramustine—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.00124	0.00601	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.00119	0.00578	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.00118	0.00573	CbGpPWpGaD
Estramustine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.00118	0.00571	CbGpPWpGaD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—thyroid cancer	0.00116	0.00562	CbGpPWpGaD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—HRAS—thyroid cancer	0.00115	0.00559	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.00115	0.00559	CbGpPWpGaD
Estramustine—Tinnitus—Epirubicin—thyroid cancer	0.00111	0.00284	CcSEcCtD
Estramustine—Flushing—Epirubicin—thyroid cancer	0.0011	0.00282	CcSEcCtD
Estramustine—ABCB1—lymph node—thyroid cancer	0.00109	0.00479	CbGeAlD
Estramustine—ESR1—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00109	0.00529	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—TERT—thyroid cancer	0.00107	0.00517	CbGpPWpGaD
Estramustine—Alopecia—Epirubicin—thyroid cancer	0.00105	0.00269	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.00104	0.00504	CbGpPWpGaD
Estramustine—Tinnitus—Doxorubicin—thyroid cancer	0.00103	0.00262	CcSEcCtD
Estramustine—Flushing—Doxorubicin—thyroid cancer	0.00102	0.00261	CcSEcCtD
Estramustine—Flatulence—Epirubicin—thyroid cancer	0.00102	0.00261	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—AKT1—thyroid cancer	0.00102	0.00494	CbGpPWpGaD
Estramustine—Muscle spasms—Epirubicin—thyroid cancer	0.000996	0.00255	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—HIF1A—thyroid cancer	0.000995	0.00483	CbGpPWpGaD
Estramustine—Alopecia—Doxorubicin—thyroid cancer	0.000973	0.00249	CcSEcCtD
Estramustine—ESR1—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000971	0.00471	CbGpPWpGaD
Estramustine—Flatulence—Doxorubicin—thyroid cancer	0.000944	0.00241	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000932	0.00452	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000928	0.0045	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—TRIM33—thyroid cancer	0.000927	0.0045	CbGpPWpGaD
Estramustine—Leukopenia—Epirubicin—thyroid cancer	0.000927	0.00237	CcSEcCtD
Estramustine—Muscle spasms—Doxorubicin—thyroid cancer	0.000921	0.00236	CcSEcCtD
Estramustine—ESR1—FOXM1 transcription factor network—CCND1—thyroid cancer	0.000905	0.00439	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—MEN1—thyroid cancer	0.000884	0.00429	CbGpPWpGaD
Estramustine—Chest pain—Epirubicin—thyroid cancer	0.000882	0.00225	CcSEcCtD
Estramustine—Anxiety—Epirubicin—thyroid cancer	0.000879	0.00225	CcSEcCtD
Estramustine—Leukopenia—Doxorubicin—thyroid cancer	0.000858	0.00219	CcSEcCtD
Estramustine—Oedema—Epirubicin—thyroid cancer	0.000845	0.00216	CcSEcCtD
Estramustine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000828	0.00212	CcSEcCtD
Estramustine—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000817	0.00396	CbGpPWpGaD
Estramustine—Chest pain—Doxorubicin—thyroid cancer	0.000816	0.00209	CcSEcCtD
Estramustine—ESR1—Estrogen signaling pathway—AKT1—thyroid cancer	0.000815	0.00395	CbGpPWpGaD
Estramustine—Anxiety—Doxorubicin—thyroid cancer	0.000813	0.00208	CcSEcCtD
Estramustine—Anorexia—Epirubicin—thyroid cancer	0.000806	0.00206	CcSEcCtD
Estramustine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000798	0.00387	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—NRAS—thyroid cancer	0.000795	0.00385	CbGpPWpGaD
Estramustine—Oedema—Doxorubicin—thyroid cancer	0.000782	0.002	CcSEcCtD
Estramustine—ESR1—Signaling by ERBB4—CDK1—thyroid cancer	0.000777	0.00377	CbGpPWpGaD
Estramustine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000766	0.00196	CcSEcCtD
Estramustine—Insomnia—Epirubicin—thyroid cancer	0.000764	0.00195	CcSEcCtD
Estramustine—Dyspnoea—Epirubicin—thyroid cancer	0.000754	0.00193	CcSEcCtD
Estramustine—Anorexia—Doxorubicin—thyroid cancer	0.000745	0.00191	CcSEcCtD
Estramustine—Decreased appetite—Epirubicin—thyroid cancer	0.000735	0.00188	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000725	0.00352	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000721	0.0035	CbGpPWpGaD
Estramustine—Insomnia—Doxorubicin—thyroid cancer	0.000707	0.00181	CcSEcCtD
Estramustine—ESR1—Generic Transcription Pathway—THRB—thyroid cancer	0.000702	0.00341	CbGpPWpGaD
Estramustine—Dyspnoea—Doxorubicin—thyroid cancer	0.000697	0.00178	CcSEcCtD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.00069	0.00335	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—CCND1—thyroid cancer	0.00069	0.00334	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—KRAS—thyroid cancer	0.000684	0.00332	CbGpPWpGaD
Estramustine—Decreased appetite—Doxorubicin—thyroid cancer	0.00068	0.00174	CcSEcCtD
Estramustine—ESR2—Gene Expression—THRB—thyroid cancer	0.00067	0.00325	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.000646	0.00313	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000624	0.00303	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—NRG1—thyroid cancer	0.000623	0.00302	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—CCND1—thyroid cancer	0.000616	0.00299	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—CCND1—thyroid cancer	0.000602	0.00292	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000601	0.00291	CbGpPWpGaD
Estramustine—Pruritus—Epirubicin—thyroid cancer	0.000598	0.00153	CcSEcCtD
Estramustine—ESR2—Generic Transcription Pathway—RXRA—thyroid cancer	0.000592	0.00287	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000592	0.00287	CbGpPWpGaD
Estramustine—ESR1—LKB1 signaling events—TP53—thyroid cancer	0.000585	0.00284	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—HRAS—thyroid cancer	0.000581	0.00282	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—PTEN—thyroid cancer	0.000581	0.00282	CbGpPWpGaD
Estramustine—Diarrhoea—Epirubicin—thyroid cancer	0.000578	0.00148	CcSEcCtD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000577	0.0028	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—CCND1—thyroid cancer	0.000569	0.00276	CbGpPWpGaD
Estramustine—Pruritus—Doxorubicin—thyroid cancer	0.000553	0.00141	CcSEcCtD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000552	0.00268	CbGpPWpGaD
Estramustine—Vomiting—Epirubicin—thyroid cancer	0.000537	0.00137	CcSEcCtD
Estramustine—Diarrhoea—Doxorubicin—thyroid cancer	0.000535	0.00137	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000534	0.00259	CbGpPWpGaD
Estramustine—Rash—Epirubicin—thyroid cancer	0.000533	0.00136	CcSEcCtD
Estramustine—Dermatitis—Epirubicin—thyroid cancer	0.000532	0.00136	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.00053	0.00257	CbGpPWpGaD
Estramustine—Headache—Epirubicin—thyroid cancer	0.000529	0.00135	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000516	0.0025	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—AKT1—thyroid cancer	0.000513	0.00249	CbGpPWpGaD
Estramustine—Nausea—Epirubicin—thyroid cancer	0.000502	0.00128	CcSEcCtD
Estramustine—Vomiting—Doxorubicin—thyroid cancer	0.000497	0.00127	CcSEcCtD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000494	0.0024	CbGpPWpGaD
Estramustine—Rash—Doxorubicin—thyroid cancer	0.000493	0.00126	CcSEcCtD
Estramustine—Dermatitis—Doxorubicin—thyroid cancer	0.000493	0.00126	CcSEcCtD
Estramustine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000492	0.00238	CbGpPWpGaD
Estramustine—Headache—Doxorubicin—thyroid cancer	0.00049	0.00125	CcSEcCtD
Estramustine—ESR1—Gene Expression—TRIM33—thyroid cancer	0.000468	0.00227	CbGpPWpGaD
Estramustine—Nausea—Doxorubicin—thyroid cancer	0.000465	0.00119	CcSEcCtD
Estramustine—ESR2—Gene Expression—TPR—thyroid cancer	0.000453	0.0022	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—MEN1—thyroid cancer	0.000446	0.00216	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.000446	0.00216	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—MEN1—thyroid cancer	0.000426	0.00206	CbGpPWpGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000401	0.00194	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TP53—thyroid cancer	0.000396	0.00192	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000396	0.00192	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—PPARG—thyroid cancer	0.000374	0.00181	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—HRAS—thyroid cancer	0.000359	0.00174	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000352	0.00171	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—AKT1—thyroid cancer	0.000342	0.00166	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—THRB—thyroid cancer	0.000338	0.00164	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000325	0.00158	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CALCB—thyroid cancer	0.000321	0.00156	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000318	0.00154	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—AKT1—thyroid cancer	0.000317	0.00154	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000314	0.00152	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PTEN—thyroid cancer	0.000312	0.00151	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TRIM33—thyroid cancer	0.000304	0.00147	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—RXRA—thyroid cancer	0.000298	0.00145	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000298	0.00145	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000298	0.00144	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000297	0.00144	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—RXRA—thyroid cancer	0.000285	0.00138	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—NRAS—thyroid cancer	0.000279	0.00135	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.00027	0.00131	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.00026	0.00126	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—MINPP1—thyroid cancer	0.000254	0.00123	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000241	0.00117	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—KRAS—thyroid cancer	0.00024	0.00116	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—TPR—thyroid cancer	0.000228	0.00111	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NDUFA13—thyroid cancer	0.000216	0.00105	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—MEN1—thyroid cancer	0.000215	0.00104	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000214	0.00104	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	0.000213	0.00103	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—HRAS—thyroid cancer	0.000204	0.000988	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CHST14—thyroid cancer	0.000203	0.000984	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TCF7L1—thyroid cancer	0.000203	0.000984	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000201	0.000973	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000201	0.000973	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.0002	0.000969	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000197	0.000957	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—PPARG—thyroid cancer	0.000188	0.000913	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	0.000186	0.0009	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.000181	0.000877	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—AKT1—thyroid cancer	0.00018	0.000873	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—PPARG—thyroid cancer	0.00018	0.000872	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000178	0.000861	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—HPGD—thyroid cancer	0.000164	0.000793	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000158	0.000765	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—MINPP1—thyroid cancer	0.000156	0.000758	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00015	0.000728	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.00015	0.000727	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TSHR—thyroid cancer	0.000148	0.00072	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000146	0.000708	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—RXRA—thyroid cancer	0.000144	0.000696	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000143	0.000691	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MEN1—thyroid cancer	0.00014	0.000677	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000138	0.000667	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	0.000133	0.000645	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PTCH1—thyroid cancer	0.000126	0.000612	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000126	0.000612	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CHST14—thyroid cancer	0.000125	0.000606	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SST—thyroid cancer	0.000115	0.00056	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CALCA—thyroid cancer	0.000111	0.000539	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000106	0.000512	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—HPGD—thyroid cancer	0.000101	0.000489	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CDK1—thyroid cancer	0.000101	0.000488	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—TPR—thyroid cancer	9.39e-05	0.000456	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	9.39e-05	0.000455	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	9.24e-05	0.000448	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—PPARG—thyroid cancer	9.07e-05	0.00044	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NRG1—thyroid cancer	8.08e-05	0.000392	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	7.93e-05	0.000385	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TERT—thyroid cancer	7.25e-05	0.000352	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—AKT1—thyroid cancer	7.11e-05	0.000345	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SLC5A5—thyroid cancer	7.03e-05	0.000341	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HIF1A—thyroid cancer	6.93e-05	0.000336	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—RXRA—thyroid cancer	5.91e-05	0.000287	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—TPR—thyroid cancer	5.79e-05	0.000281	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—BRAF—thyroid cancer	5.74e-05	0.000278	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	5.69e-05	0.000276	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	4.33e-05	0.00021	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CCND1—thyroid cancer	4.19e-05	0.000203	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PTEN—thyroid cancer	4.04e-05	0.000196	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PPARG—thyroid cancer	3.73e-05	0.000181	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—RXRA—thyroid cancer	3.64e-05	0.000177	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NRAS—thyroid cancer	3.61e-05	0.000175	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—AKT1—thyroid cancer	3.59e-05	0.000174	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KRAS—thyroid cancer	3.11e-05	0.000151	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTGS2—thyroid cancer	2.93e-05	0.000142	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TP53—thyroid cancer	2.76e-05	0.000134	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HRAS—thyroid cancer	2.64e-05	0.000128	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTEN—thyroid cancer	2.56e-05	0.000124	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AKT1—thyroid cancer	2.33e-05	0.000113	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PPARG—thyroid cancer	2.3e-05	0.000111	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.81e-05	8.77e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTEN—thyroid cancer	1.58e-05	7.65e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—AKT1—thyroid cancer	1.48e-05	7.15e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—AKT1—thyroid cancer	9.09e-06	4.41e-05	CbGpPWpGaD
